Table of contents
Cellulitis
What's new
Updated 2024 ESCMID guidelines for laboratory testing and antimicrobial stewardship in cellulitis and erysipelas in the emergency department.
Background
Overview
Guidelines
Key sources
Diagnostic investigations
More topics in this section
Blood and skin cultures
MRSA PCR
Diagnostic imaging
Medical management
More topics in this section
Management of underlying conditions
Antibiotic therapy (initial empiric therapy)
Antibiotic therapy (duration)
Antibiotic therapy (MRSA coverage)
Adjunctive corticosteroids
Nonpharmacologic interventions
Surgical interventions
Specific circumstances
More topics in this section
Immunocompromised patients (evaluation)
Immunocompromised patients (management)
Patients with cellular immunodeficiency
Patients with febrile neutropenia (evaluation)
Patients with febrile neutropenia (management)
Patients with febrile neutropenia (persistent/recurrent episodes)
Patients with Vibrio vulnificus infection
Follow-up and surveillance
More topics in this section
Management of recurrent cellulitis (predisposing conditions)
Management of recurrent cellulitis (hygiene practices)
Management of recurrent cellulitis (prophylactic antibiotics)
Management of recurrent cellulitis (decolonization strategies)